Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
NCT ID: NCT04600375
Last Updated: 2022-04-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2020-10-20
2020-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hidradenitis Suppurativa Written Action Plan
NCT04230291
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
NCT00494351
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
NCT01063270
Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
NCT02805595
Impact of Hidradenitis Suppurativa on Quality of Life Functions
NCT03288337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verbal Consultation, then Written Action Plan
CONTROL GROUP
1. Survey A
2. Routine clinic visit
3. Verbal consultation only
4. Survey B
5. Verbal consultation AND Written Action Plan
6. Survey C
Verbal consultation
Verbal consultation only without written information before receiving written action plan
Written Action Plan
Written handout of treatment plan and disease management strategies
Experimental: Written Action Plan
INTERVENTION GROUP
1. Survey A
2. Routine clinic visit
3. Verbal consultation AND Written Action Plan
4. Survey C
Written Action Plan
Written handout of treatment plan and disease management strategies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verbal consultation
Verbal consultation only without written information before receiving written action plan
Written Action Plan
Written handout of treatment plan and disease management strategies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of HS by a board-certified dermatologist
* Able to read and comprehend study materials
* No prior exposure to written HS action plans
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vivian Y Shi, MD
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Thompson AM, Fernandez JM, Shih T, Hamzavi I, Hsiao JL, Shi VY. Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial. J Dermatolog Treat. 2022 Aug;33(5):2677-2679. doi: 10.1080/09546634.2021.1970707. Epub 2021 Sep 27.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
261683
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.